EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 120 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 4.58 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $67,700,000 | +25.6% | 853,285 | +10.8% | 0.01% | +9.1% |
| Q3 2016 | $53,891,000 | +237.4% | 769,869 | +87.0% | 0.01% | +175.0% |
| Q2 2016 | $15,971,000 | -3.6% | 411,735 | +0.6% | 0.00% | 0.0% |
| Q1 2016 | $16,574,000 | -52.5% | 409,234 | +4.1% | 0.00% | -50.0% |
| Q4 2015 | $34,856,000 | +130.2% | 393,097 | +92.2% | 0.01% | +100.0% |
| Q3 2015 | $15,139,000 | -8.9% | 204,499 | -0.5% | 0.00% | 0.0% |
| Q2 2015 | $16,615,000 | +4366.4% | 205,479 | +2215.0% | 0.00% | – |
| Q1 2015 | $372,000 | +644.0% | 8,876 | +174.7% | 0.00% | – |
| Q4 2014 | $50,000 | -95.0% | 3,231 | -95.9% | 0.00% | – |
| Q1 2014 | $1,003,000 | – | 78,665 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 112,666 | $1,777 | 0.65% |
| Smith, Graham & Co., Investment Advisors, LP | 273,099 | $4,306,771 | 0.54% |
| BRANDES INVESTMENT PARTNERS, LP | 1,134,363 | $17,888,904 | 0.35% |
| TANG CAPITAL MANAGEMENT LLC | 118,857 | $1,874,375 | 0.26% |
| Virtus Investment Advisers, Inc. | 20,867 | $329,073 | 0.22% |
| DENALI ADVISORS LLC | 32,300 | $509,371 | 0.18% |
| Nebula Research & Development LLC | 11,473 | $180,929 | 0.10% |
| SCOUT INVESTMENTS, INC. | 131,192 | $1,995,430 | 0.05% |
| XTX Topco Ltd | 15,050 | $237,339 | 0.04% |
| PDT Partners, LLC | 19,745 | $311,379 | 0.04% |